Claim Validation

Please provide us info to confirm the ownership and validate your claim.
Characters missing: 50
Ok, message sent.
Message not sent.



Johnson & Johnson Single Dose Vaccine Gets Cleared by FDA


The U.S. is getting a third COVID-19 vaccine, as the Food and Drug Administration on Saturday cleared a Johnson & Johnson shot that works with just one dose instead of 2 like Pfizer and Moderna vaccine shots.

Health experts are anxiously awaiting a one-and-done option to help speed vaccinations, as they race against a virus that already has killed more than 510,000 people in the U.S. and is mutating in increasingly worrisome ways.

The FDA said J&J’s vaccine offers strong protection against what matters most: serious illness, hospitalizations, and death. One dose was 85% protective against the most severe COVID-19 illness, in a massive study that spanned 3 continents — protection that remained strong even in countries such as South Africa, where the variants of most concern are spreading.

“The more vaccines that have high efficacy that we can get into play, the better,” Dr. Anthony Fauci, the top U.S. infectious disease expert, said ahead of the FDA’s ruling.

Shipments of a few million doses to be divided among states could begin as early as Monday to some countries. By the end of March, Johnson & Johnson has said it hopes to deliver 20 million doses to the United States, and 100 million by summer to the entire country.

The company aims to produce about 1 billion doses globally by the end of the year. On Thursday, the island nation of Bahrain became the first to clear its use. It is not cleared to use in Europe as of yet.